OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management Programme
- Status
- RecruitingResults none
- Why it is watched
- non-weight indication: cardiovascular
- Who it enrolls
- age 18 Years to 65 Years; BMI ≥30 required; conditions: Obesity Difficult Airway Airway Management; Obesity Adult Onset; Obesity and Cardiovascular Risk; Obesity Type 2 Diabetes Mellitus
- Interventions
- Semaglutide (Wegovy) weekly injection; Behavioral Treatment; Weight loss
- Conditions
- Obesity Difficult Airway Airway Management; Obesity Adult Onset; Obesity and Cardiovascular Risk; Obesity Type 2 Diabetes Mellitus
- Phase and size
- NA · 300 participants
- Dates
- Start 2026-01-22
Primary completion 2028-01-23 - Sponsor
- University of Health Sciences, Algeria (Other)
- Last checked
- Sep 13, 2026
01Endpoints
What the trial will measure
- Percentage of Participants Achieving ≥5% Weight Loss at Month 1818 months follow-up
02Eligibility
Who can take part
Inclusion Criteria: * Adults aged 18-65 years * BMI ≥30 kg/m² * Written informed consent obtained prior to enrolment Exclusion Criteria: * Refusal to participate or inability to adhere to follow-up procedures * Pregnancy at enrolment * Severe or unstable comorbidities compromising safety or participation, including: * Recent acute cardiovascular event (\<60 days) * Active malignancy * Severe unstable organic disease * Previous bariatric surgery * Obesity pharmacotherapy within the previous 90 days * Known contraindication to planned therapeutic options * Severe unstable psychiatric disorders * Genetic obesity or obesity secondary to uncontrolled endocrine disease Exclusion Criteria During Follow-up * Pregnancy occurring during follow-up * Initiation of chronic treatment associated with weight gain
03Change log
Registry changes
No changes recorded since the trial was added.